Business News • MarketWire • Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants |
Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants |
|
|
Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
THOROFARE, NJ--(Marketwired - Jan 9, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, today announces the entry into an agreement relating to the sale of 1,667,000 shares of common stock at a public offering price of $1.20 per share together with the issuance of 833,500 five-year warrants to purchase common stock with an exercise price of $1.50. The gross proceeds from the offering, excluding any proceeds on the exercise of the warrants, are expected to be approximately $2,000,400, before deducting the underwriting discount and estimated offering expenses. The funds raised will be used for working capital as well as to accelerate growth in the US and in international markets, further develop new customers and launch new diagnostic products.
View More : http://www.marketwired.com/mw/release.do?id=2187100&sourceType=3
|
|
|